METTL3 and glioblastoma: Meanwhile, another group of researchers found that METTL3 upregulation was observed to predict poorer patient survival and increased SOX2 mRNA expression and stability, promoting the growth of glioblastoma stem cells and shortening the survival time of mice [118].